Scorpius Holdings Announces Partnership with U.S. Biotech Company
October 22, 2024
Evofem Biosciences Announces Strong Preliminary Results for the First Quarter of 2023
June 1, 2023
Related Post
-
-
Quoin Pharmaceuticals Announces Further International Expansion of Ongoing Clinical Trials for Netherton Syndrome
October 22, 2024
-
Bright Minds Biosciences and Firefly Neuroscience to Collaborate After the BREAKTHROUGH Study: A Phase 2 Trial of BMB-101 in Absence Epilepsy and Developmental Epileptic Encephalopathy for Full Analysis of EEG Data
October 21, 2024
-
Kane Biotech Announces Exclusive Distribution Agreement With XSONX
October 17, 2024